FEMASYS INC (FEMY)

↓ Download CSV

CIK 0001339005 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, FEMASYS INC reported revenue of $2.29M, up 40.8% from the prior year. The company ran a net loss, with a net margin of -812.3%. It held $20.72M in total assets against $14.85M in total liabilities.

Key ratios (FY2025)

-767.0%
Operating margin
-812.3%
Net margin
-317.4%
Return on equity
+40.8%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019
Revenue$2.29M$1.63M$1.07M$1.21M$1.18M$1.04M
Cost of Revenue$872.4K$544.9K$380.1K$441.9K$370.4K$306.5K
Gross Profit$764.3K$809.3K$731.4K
Operating Income-$17.59M-$17.79M-$14.51M-$11.60M-$8.34M-$6.93M
Net Income-$18.63M-$18.82M-$14.25M-$11.39M-$7.54M-$6.91M
EPS (Diluted)$-0.47$-0.85$-0.93$-0.96$-1.12$-7.20
Total Assets$20.72M$12.45M$27.76M$16.90M$28.58M$7.61M
Total Liabilities$14.85M$10.14M$9.40M$1.65M$2.24M$4.08M
Shareholders' Equity$5.87M$2.30M$18.35M$15.24M$26.33M-$51.82M-$45.37M
Cash & Equivalents$9.27M$3.45M$21.72M$12.96M$24.78M$3.32M
Operating Cash Flow-$18.69M-$19.44M-$11.28M-$10.73M-$7.93M-$4.93M
Capital Expenditures$525.0K$761.7K$143.9K$407.5K$306.9K$8.4K
Shares Outstanding59.60M23.36M21.66M11.87M11.80M993.1K